Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amgen Inc (NASDAQ:AMGN)

154.67
Delayed Data
As of 4:00pm ET
 +0.87 / +0.57%
Today’s Change
133.64
Today|||52-Week Range
176.85
+5.79%
Year-to-Date

Today’s Trading

Previous close153.80
Today’s open154.71
Day’s range153.82 - 155.35
Volume3,067,088
Average volume (3 months)3,756,912
Market cap$114.4B
Dividend yield2.97%
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)+35.22%
Earnings growth (this year)+11.28%
Earnings growth (next 5 years)+8.00%
Revenue growth (last year)+6.49%
P/E ratio15.5
Price/Sales5.83
Price/Book4.13

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences-0.56-0.78%
BIIBBiogen+0.31+0.11%
ILMNIllumina Inc-0.84-0.52%
ARIAARIAD Pharmaceutical...+0.05+0.21%
Data as of 4:00pm ET, 01/20/2017

Financials

Next reporting dateFebruary 2, 2017
EPS forecast (this quarter)$2.79
Annual revenue (last year)$21.3B
Annual profit (last year)$6.9B
Net profit margin32.52%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Esteban Santos
Corporate headquarters
Thousand Oaks, California

Forecasts


Search for Jobs